Article: Push For Public Posting Of Clinical Trial Data Continues.

Washington Editor

WASHINGTON - A pair of House Democrats on Thursday vowed to introduce legislation that would require drug companies to publish information on ongoing clinical trials and the results, whether positive or negative.

During a House Energy and Commerce Subcommittee on Oversight and Investigations hearing, Rep. Henry Waxman (D-Calif.), an author of the pending legislation, said the bill would expand the FDA's current clinical trial registry to ensure that physicians, patients and the public have access to information learned in all studies.

"The legislation will also prevent pharmaceutical companies from withholding clinically ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!